![]() Celyad Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology. | ![]() Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
| ![]() Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics. | |
Founding Date | Founding Date 2007 | Founding Date 2006 | Founding Date 1989 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Mont-Saint-Guibert, BE HQ New York, US | Locations San Diego, US HQ San Diego, US | Locations Carlsbad, US HQ |
Employees | Employees 17 | Employees 31019% decrease | Employees 92716% increase |
Valuation ($) | Valuation ($) 11.8 m | Valuation ($) 1.5 m | Valuation ($) 6.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) €102k (FY, 2023) | Revenue (est.) $62.8m (FY, 2022) | Revenue (est.) $787.6m (FY, 2023) |
Cost of goods | Cost of goods €69k (FY, 2023) | Cost of goods N/A | Cost of goods $9.1m (FY, 2023) |
Gross profit | Gross profit €1.4m (FY, 2023) | Gross profit N/A | Gross profit $778.5m (FY, 2023) |
Net income | Net income (€8.4m) (FY, 2023) | Net income ($577.8m) (FY, 2022) | Net income ($366.3m) (FY, 2023) |
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
View companyIonis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
View company